Ceribell Files Patent Lawsuit Over Wearable EEG Technology
Ceribell, maker of an FDA-cleared bedside wearable EEG, has sued a competitor for patent infringement over seizure-detection technology, Bloomberg Law reports.
Updated

Ceribell, the company behind a Food and Drug Administration-cleared rapid-response wearable EEG system used at the bedside for seizure detection, has filed a patent infringement lawsuit against a competitor in the wearable EEG space, Bloomberg Law reports.
The suit, filed in federal court, marks an escalation of intellectual property disputes in a segment of clinical neurophysiology that has grown quickly as hospitals adopt point-of-care brain monitoring for critically ill patients.
What is at stake?
Ceribell's core product is a headband-based scalp EEG system paired with automated analysis software, designed to let non-specialist clinicians detect seizures — including nonconvulsive status epilepticus — in emergency departments and intensive care units within minutes rather than hours.
At issue in the litigation are patents covering wearable EEG hardware and, potentially, the signal-processing methods that turn raw scalp recordings into clinician-readable seizure alerts. Bloomberg Law's report identifies the dispute as targeting a direct competitor marketing a wearable EEG device.
Why does this matter for the reading room?
Patent litigation in this niche signals commercial maturity. When companies fight over intellectual property for disposable EEG headbands and automated interpretation, it confirms that hospital procurement of rapid bedside EEG has moved from pilot projects to standardized monitoring-unit workflow.
For neurophysiologists, the practical implications include:
- Which rapid EEG platforms remain available and cleared as litigation proceeds
- Whether hardware or algorithm changes follow from any settlement or injunction
- How certification and training pathways for bedside EEG triage evolve as vendors consolidate
What comes next?
Court filings will determine the scope of the patents at issue and whether Ceribell seeks an injunction against sales of the competing device. A trial date, potential settlement, or licensing agreement could reshape which wearable EEG systems reach intensive care units and emergency departments in the coming years.
Based on
Source: Google News: Wearable EEG.
Tom Whitfield
Show full bio
Senior reporter covering people, launches and day-to-day practice in Clinical neurophysiology and EEG interpretation at EEG Signal.